Zevra Therapeutics (1GDA.F) Q1 2025 Earnings

11MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.65
-0.55
-0.46
-0.36

Details

Expected EPS
-0.3618832
Actual EPS
-0.6138272
Surprise EPS
-0.25
Surprise Percent
+69.62%

Description

Zevra Therapeutics (1GDA.F) has reported earnings of -0.6138272 per share for Q1 2025.

0 Comments

Share your thoughts